Treatment of acute hepatitis C in an HIV-positive man with pegylated interferon and ribavirin for 24 weeks

Nila Rafiq, Damaris Carriero, Allison Uriel, Douglas T. Dieterich

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

An epidemic of acute hepatitis C is emerging among HIV-infected men who have sex with men (MSM), with a growing number of cases reported in the MSM population in the United States and Europe. We report a case of a 47-year-old HIV-infected MSM who sexually contracted acute hepatitis C and was treated with pegylated interferon and ribavirin for 24 weeks. After 4 weeks of therapy, the patient's HCV RNA level became undetectable and remained undetectable 1 year after the 24-week treatment course.

Original languageEnglish
Pages (from-to)561-564
Number of pages4
JournalAIDS Reader
Volume17
Issue number11
StatePublished - Nov 2007
Externally publishedYes

Keywords

  • HIV/AIDS
  • HIV/HCV coinfection
  • Hepatitis C
  • Interferon
  • Ribavirin

Fingerprint

Dive into the research topics of 'Treatment of acute hepatitis C in an HIV-positive man with pegylated interferon and ribavirin for 24 weeks'. Together they form a unique fingerprint.

Cite this